I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Bleomycin sulfate is used as a glycopeptide antibiotic. It is capable of inducing oxidative cleavage of the DNA backbone, leading to apoptosis and also degrades RNA, and has been reported to display selectivity for RNA over DNA. Bleomycin acts as a sclerosing agent.
WB Shelley.; ED Shelley. Intralesional bleomycin sulfate therapy for warts: a novel bifurcated needle puncture technique. Arch Dermatol. 1991, 127,(2), 234-236.
M Amer.; N Diab.; A Ramadan.; A Galal. Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts. Journal of the American Academy of Dermatology. 2015, 73,(4), 533-720.
Hazard Statements: H340-H351
May cause genetic defects. Suspected of causing cancer.
Precautionary Statements: P201-P280-P202-P308+P313-P405-P501a
Obtain special instructions before use. Wear protective gloves/protective clothing/eye protection/face protection. Do not handle until all safety precautions have been read and understood. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.